Navigation

 


Kidney Cancer

Minimally invasive kidney cancer treatment promising

A recent study has found that radiofrequency ablation can be an effective minimally invasive treatment for kidney cancer, according to a July 2, 2004, news release from Big News Network.com. In a three-year study, researchers from Wake Forest University Baptist Medical Center, Winston-Salem, NC, evaluated 22 participants who had kidney cancer that had not spread beyond the kidney. In 83% of participants, tumors were eliminated after a single treatment of radiofrequency ablation, and in an additional 8% of participants, tumors were eradicated after two or more treatments. None of the participants in the study suffered any serious Long-term complications.

Radiofrequency ablation is becoming more common for the treatment of several diseases, including heart arrhythmias. The procedure uses tomography technology to guide a needle-shaped electrode into the tumor. A radiofrequency current then is passed through the electrode, heating the tumor tissue and eradicating it.

New Kidney Cancer Treatment Promising (news release, Sydney: Big News Network.com, duly 2, 2004) http:// feeds.bignewsnetwork.com/?sid=26f765a5feb8484d (accessed 6 duly 2004).

COPYRIGHT 2004 Association of Operating Room Nurses, Inc.
COPYRIGHT 2004 Gale Group



Kidney Cancer
American Cancer Association
Mouth Cancer
Cancer Research
Types Of Cancer
Pancreas Cancer
Signs Of Cancer
Tongue Cancer
Lymph Node Cancer
Cancer Society
Fox Chase Cancer Center
Cancer Horoscope
Cancer Cure
Esophageal Cancer
Colorectal Cancer
Rectal Cancer
Esophagus Cancer
Zodiac Sign Cancer
Cervix Cancer
Endometrial Cancer
Stages Of Cancer
Melanoma Cancer
Blood Cancer
Cancer Cells
Bob Denver Cancer
Cancer In Dogs
Cancer Astrology
Stage 4 Cancer
Cancer Bracelets
Natural Cures For Cancer
Causes Of Cancer
Bowel Cancer
Cancer Survivors Network
Uterus Cancer
Squamous Cell Cancer
Gastric Cancer
Cancer Prevention
Lip Cancer
Cancer Statistics
Basal Cell Cancer

Copyright © 2005 Drug-Store.co.uk All Rights Reserved.